128 related articles for article (PubMed ID: 2106676)
1. Absorption enhancement of rectally infused insulin by sodium tauro-24,25-dihydrofusidate (STDHF) in rats.
van Hoogdalem EJ; Heijligers-Feijen CD; Verhoef JC; de Boer AG; Breimer DD
Pharm Res; 1990 Feb; 7(2):180-3. PubMed ID: 2106676
[TBL] [Abstract][Full Text] [Related]
2. Rectal absorption enhancement of cefoxitin and desglycinamide arginine vasopressin by sodium tauro-24,25-dihydrofusidate in conscious rats.
van Hoogdalem EJ; Heijligers-Feijen CD; Mathôt RA; Wackwitz AT; van Bree JB; Verhoef JC; de Boer AG; Breimer DD
J Pharmacol Exp Ther; 1989 Nov; 251(2):741-4. PubMed ID: 2810123
[TBL] [Abstract][Full Text] [Related]
3. Absorption enhancement of intranasally administered insulin by sodium taurodihydrofusidate (STDHF) in rabbits and rats.
Deurloo MJ; Hermens WA; Romeyn SG; Verhoef JC; Merkus FW
Pharm Res; 1989 Oct; 6(10):853-6. PubMed ID: 2692018
[TBL] [Abstract][Full Text] [Related]
4. The effect of sodium tauro-24,25-dihydrofusidate on the nasal absorption of human growth hormone in three animal models.
Baldwin PA; Klingbeil CK; Grimm CJ; Longenecker JP
Pharm Res; 1990 May; 7(5):547-52. PubMed ID: 2367323
[TBL] [Abstract][Full Text] [Related]
5. Intranasal bioavailability of insulin powder formulations: effect of permeation enhancer-to-protein ratio.
Lee WA; Narog BA; Patapoff TW; Wang YJ
J Pharm Sci; 1991 Aug; 80(8):725-9. PubMed ID: 1791529
[TBL] [Abstract][Full Text] [Related]
6. Tolerability and absorption enhancement of intranasally administered octreotide by sodium taurodihydrofusidate in healthy subjects.
Kissel T; Drewe J; Bantle S; Rummelt A; Beglinger C
Pharm Res; 1992 Jan; 9(1):52-7. PubMed ID: 1589410
[TBL] [Abstract][Full Text] [Related]
7. Effects of sodium taurodihydrofusidate on nasal absorption of insulin in sheep.
Longenecker JP; Moses AC; Flier JS; Silver RD; Carey MC; Dubovi EJ
J Pharm Sci; 1987 May; 76(5):351-5. PubMed ID: 3309255
[TBL] [Abstract][Full Text] [Related]
8. Permeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assessment of effect-reversibility and imaging of transepithelial transport routes by confocal laser scanning microscopy.
Hurni MA; Noach AB; Blom-Roosemalen MC; de Boer AG; Nagelkerke JF; Breimer DD
J Pharmacol Exp Ther; 1993 Nov; 267(2):942-50. PubMed ID: 7504101
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of bile acids and fusidate derivative as nasal absorption enhancers using an electrophysiological technique.
Hosoya K; Kubo H; Natsume H; Sugibayashi K; Morimoto Y
Biol Pharm Bull; 1999 Oct; 22(10):1089-93. PubMed ID: 10549861
[TBL] [Abstract][Full Text] [Related]
10. The bioavailability of intranasal salmon calcitonin in healthy volunteers with and without a permeation enhancer.
Lee WA; Ennis RD; Longenecker JP; Bengtsson P
Pharm Res; 1994 May; 11(5):747-50. PubMed ID: 8058647
[TBL] [Abstract][Full Text] [Related]
11. Effects of absorption enhancers on human nasal tissue ciliary movement in vitro.
Hermens WA; Hooymans PM; Verhoef JC; Merkus FW
Pharm Res; 1990 Feb; 7(2):144-6. PubMed ID: 2408030
[TBL] [Abstract][Full Text] [Related]
12. Topical effects of absorption enhancing agents on the rectal mucosa of rats in vivo.
van Hoogdalem EJ; Vermeij-Kerrs C; de Boer AG; Breimer DD
J Pharm Sci; 1990 Oct; 79(10):866-70. PubMed ID: 2280353
[TBL] [Abstract][Full Text] [Related]
13. The effects of permeation enhancers on the surface morphology of the rat nasal mucosa: a scanning electron microscopy study.
Ennis RD; Borden L; Lee WA
Pharm Res; 1990 May; 7(5):468-75. PubMed ID: 2367314
[TBL] [Abstract][Full Text] [Related]
14. Effect of sodium salicylate on insulin rectal absorption in humans.
Hosny E; el-Ahmady O; el-Shattawy H; Nabih A el-M ; el-Damacy H; Gamal-el-Deen S; el-Kabbany N
Arzneimittelforschung; 1994 May; 44(5):611-3. PubMed ID: 8024632
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of insulin-loaded acrylic hydrogels containing absorption enhancers.
Uchida T; Toida Y; Sakakibara S; Miyanaga Y; Tanaka H; Nishikata M; Tazuya K; Yasuda N; Matsuyama K
Chem Pharm Bull (Tokyo); 2001 Oct; 49(10):1261-6. PubMed ID: 11605651
[TBL] [Abstract][Full Text] [Related]
16. Site dependence of absorption-promoting actions of laureth-9, Na salicylate, Na2EDTA, and aprotinin on rectal, nasal, and buccal insulin delivery.
Aungst BJ; Rogers NJ
Pharm Res; 1988 May; 5(5):305-8. PubMed ID: 2469079
[TBL] [Abstract][Full Text] [Related]
17. The influence of concentration of two salicylate derivatives on rectal insulin absorption enhancement.
Hauss DJ; Ando HY
J Pharm Pharmacol; 1988 Sep; 40(9):659-61. PubMed ID: 2907040
[TBL] [Abstract][Full Text] [Related]
18. Vaginal absorption of insulin in the rat: effect of penetration enhancers on insulin uptake and mucosal histology.
Richardson JL; Illum L; Thomas NW
Pharm Res; 1992 Jul; 9(7):878-83. PubMed ID: 1438000
[TBL] [Abstract][Full Text] [Related]
19. Comparison of nasal, rectal, buccal, sublingual and intramuscular insulin efficacy and the effects of a bile salt absorption promoter.
Aungst BJ; Rogers NJ; Shefter E
J Pharmacol Exp Ther; 1988 Jan; 244(1):23-7. PubMed ID: 3275772
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of snail mucin motifs as rectal absorption enhancer for insulin in non-diabetic rat models.
Adikwu MU
Biol Pharm Bull; 2005 Sep; 28(9):1801-4. PubMed ID: 16141566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
